NCT05027217View on ClinicalTrials.gov

Sedation, ANalgesia and Delirium MANagement in Intensive Care Unit

CompletedOBSERVATIONAL
Enrollment

3,421

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

May 15, 2023

Study Completion Date

May 30, 2023

Conditions
Critical IllnessSedation ComplicationIntensive Care Unit DeliriumAnalgesiaCovid19
Interventions
OTHER

No intervention

No intervention. Arms are subdivided based on patients' diagnostic status on admission to ICU.

Trial Locations (1)

OX3 9DU

University of Oxford, Oxford

All Listed Sponsors
collaborator

Mount Sinai Hospital, Canada

OTHER

lead

University of Oxford

OTHER

NCT05027217 - Sedation, ANalgesia and Delirium MANagement in Intensive Care Unit | Biotech Hunter | Biotech Hunter